I have been analyzing the best options for investing in companies over the past few years, and honestly, there are interesting patterns that repeat. A couple of years ago, when markets were entering a recovery phase, some stocks emerged that were really worth keeping a close eye on.

The first thing I noticed was Nvidia’s absolute dominance in the AI chip market. When everyone was talking about artificial intelligence, this company already controlled nearly 90% of the GPU market. Its growth was tremendous, especially considering how it positioned itself against emerging competitors. Technical analysis showed sustained momentum, with the stock consistently surpassing its moving averages. For anyone considering which companies to invest in for 2024 with a tech focus, Nvidia was practically unavoidable.

Alphabet also caught my attention for different reasons. Its ecosystem is simply impressive: Google, YouTube, Android, Chrome. More than 80% of its revenue came from digital advertising, but what was interesting was its move into AI with Gemini. With free cash flow exceeding $77 billion, it had the resources to fund innovation without pressuring its margins. Its P/E ratio hovered around 29, lower than the sector average. That suggested room for growth.

Novo Nordisk was another fascinating case. The anti-obesity drug market was booming, especially with products like Ozempic. In the United States, 73% of adults suffer from overweight or obesity, and the market was projected to reach $44 billion by 2030. The company showed a 29% growth in net sales and 47% in profits during the first nine months of 2023. This was clearly a long-term trend, not a passing hype.

Berkshire Hathaway represented the more conservative side of the equation. With $157 billion in cash and a beta coefficient of 0.64, it offered stability during volatile times. Warren Buffett had demonstrated legendary ability to generate sustainable value. For investors looking to diversify portfolios without taking extreme risks, this was a solid option.

Broadcom also deserved attention. The 108% growth in 2023 was impressive, but what was really important was its acquisition of VMware. This allowed it to diversify beyond semiconductors into enterprise software, protecting against chip market volatility. With growth projections of 40% in revenue for 2024, the company was positioned for a significant expansion cycle.

Now, the question many ask is how to invest in these stocks. The answer depends on your time horizon. If you’re looking for quick gains, CFDs offer leverage and flexibility to benefit from both rises and falls. But here’s the key: CFDs carry significant risks. Losses can be amplified as quickly as gains.

For those thinking about which companies to invest in for 2024 with a medium- and long-term perspective, the strategy is different. You need to focus on companies with solid financial statements, stable growth projections, and a reliable track record. Diversification is key: spreading your investment across different sectors and companies significantly mitigates risks. You can’t get carried away by short-term fluctuations; you must stay focused on the long-term trend.

What I find interesting is that these five companies represented a fairly balanced portfolio: pharmaceutical, AI technology, financial conglomerate, and semiconductors. Each operated in different dynamics, providing natural protection against sector shocks.

The macroeconomic context was also relevant. Central bank movements regarding interest rates could cause significant fluctuations. Geopolitical tensions, U.S. presidential elections—all influenced the markets. But that also created opportunities for investors who knew where to look.

In the end, the key to deciding which companies to invest in for 2024 or any year was to do your own research, understand your risk profile, and maintain a clear strategy. It’s not about following hype but about identifying fundamental trends that will endure. That’s what made these five companies interesting: they weren’t speculative bets but solid businesses operating in sectors with real demand and structural growth.